(Q34469716)

English

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial (English)

1 reference

Europe PubMed Central

2 August 2017

author name string

Lucas M A Goossens

1

1 reference

Europe PubMed Central

2 August 2017

Inge Leimer

2

1 reference

Europe PubMed Central

2 August 2017

Norbert Metzdorf

3

1 reference

Europe PubMed Central

2 August 2017

Karin Becker

4

1 reference

Europe PubMed Central

2 August 2017

Maureen P M H Rutten-van Mölken

5

1 reference

Europe PubMed Central

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 October 2014

1 reference

Europe PubMed Central

2 August 2017

BMC Pulmonary Medicine

1 reference

Europe PubMed Central

2 August 2017

14

1 reference

Europe PubMed Central

2 August 2017

163

1 reference

Europe PubMed Central

2 August 2017

https://scigraph.springernature.com/pub.10.1186/1471-2466-14-163

0 references

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Characterisation of COPD heterogeneity in the ECLIPSE cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

The hazards of hazard ratios

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223746

6 July 2018

Do GOLD stages of COPD severity really correspond to differences in health status?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Development and first validation of the COPD Assessment Test.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Multimodel Inference: Understanding AIC and BIC in Model Selection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and Hospitalization

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-14-163

21 January 2018

Natural history of successive COPD exacerbations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25326750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surveillance for respiratory hazards in the occupational setting [American Thoracic Society]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25326750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The St George's Respiratory Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/25326750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25326750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2466-14-163

1 reference

Europe PubMed Central

2 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34469716&oldid=1754239477"